BMO Capital Upgrades ArthroCare (ARTC) to Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/14/2026
- Wall Street tumbles as hot inflation data feeds worries about Fed rate hikes
- Oil prices gain on attacks in Saudi Arabia, Iran's new tactics to target tankers
- U.S. consumer prices rise by 3.7% year-on-year in September
- Bank of America stock falls on earnings miss
- Netflix cuts 1,000 jobs as streaming giant seeks to boost engagement
Tweet
Share
E-mailGet Alerts ARTC Hot Sheet
Price: $9.99 --0%
Rating Summary:
3 Buy, 6 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 10 | New: 34
Rating Summary:
3 Buy, 6 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 10 | New: 34
Join SI Premium – FREE
BMO Capital upgraded ArthroCare (NASDAQ: ARTC) from Market Perform to Outperform, price target raised from $34 to $38.
For an analyst ratings summary and ratings history on ArthroCare click here. For more ratings news on ArthroCare click here.
Shares of ArthroCare closed at $31.07 yesterday.
For an analyst ratings summary and ratings history on ArthroCare click here. For more ratings news on ArthroCare click here.
Shares of ArthroCare closed at $31.07 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Vertical Research Partners Upgrades Lockheed Martin (LMT) to Buy, 'has some core franchises that are likely to prove resilient'
- Neo Performance Materials Inc. (NEO:CN) (NOPMF) PT Lowered to Cdn$50 at BMO Capital
- JPMorgan Upgrades China Datang Renewables Power (1798:HK) to Overweight
Create E-mail Alert Related Categories
UpgradesRelated Entities
BMO CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
